In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes.
Saved in:
| Title: | In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. |
|---|---|
| Authors: | Chanderraj R; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Medicine Service, Infectious Diseases Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA., Baker JM; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Kay SG; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Brown CA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Institute for Research on Innovation and Science, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA., Hinkle KJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Fergle DJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., McDonald RA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Falkowski NR; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Metcalf JD; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Kaye KS; Division of Infectious Diseases, Department of Medicine, Rutgers-New Jersey Medical School, Newark, NJ, USA., Woods RJ; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Medicine Service, Infectious Diseases Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.; Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA., Prescott HC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.; VA Center for Clinical Management Research, Ann Arbor, MI, USA., Sjoding MW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.; Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, USA., Dickson RP; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA rodickso@med.umich.edu.; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.; Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, USA. |
| Source: | The European respiratory journal [Eur Respir J] 2023 Feb 09; Vol. 61 (2). Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
